|

Testosterone Cypionate Clinical Trials

7 actively recruiting trials across 5 locations

Also known as: DEPO-Testosterone, DEPO-Testosterone Injection, Depo-Testosterone, Depo-Testosterone Injection, Depotest +4 more

Pipeline

Phase 1: 1Phase 2: 6

Top Sponsors

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
  • Yale University1
  • University of Washington1
  • Roswell Park Cancer Institute1

Indications

  • Cancer7
  • Metastatic Castration-resistant Prostate Cancer3
  • Castration-Resistant Prostate Carcinoma2
  • Stage IVB Prostate Cancer AJCC v82
  • Castration Resistant Metastatic Prostate Cancer1

Baltimore, Maryland3 trials

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Phase 2
The COSMYC Trial (COmbined Suppression of MYC)

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Phase 2

San Diego, California1 trial

Phase 2

New Haven, Connecticut1 trial

Buffalo, New York1 trial

Seattle, Washington1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.